US SB3346

Creates a special registration process under the Controlled Substances Act allowing physicians to administer Schedule I investigational drugs to eligible patients under the Federal Right to Try law

Requires the Attorney General to approve or deny physician registration applications within 45 days, with applications submitted electronically and including documentation of manufacturer agreements, state authorization, and relevant training

Allows physicians to request additional drug quantities through supplemental notifications that are automatically approved after 30 days unless the Attorney General issues a show cause order

Permits a single registration to cover multiple treatment sites within the same city or county if controlled by the same institution, organization, or agency

Mandates the Attorney General issue an interim final rule within 240 days of enactment covering drug delivery, storage, security, recordkeeping, and diversion controls, followed by a final rule within 2 years